Study of Biological Effects by Pulsed Bremsstrahlung Radiation of Ultrahigh Dose Rate at the Angara-5-1 Facility


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Тек жазылушылар үшін

Аннотация

Radiological methods of treatment of malignant tumors are widespread in medical practice. In addition to the type of radiation and dose and fractionation of the radiation regime, the dose rate is one of the factors that affects the effectiveness of treatment. The therapeutic dose rate lies in the range of tens of mGy/s. At modern high-current accelerators of relativistic electron beams, a significant increase in the dose rate to hundreds of MGy/s is achievable, which is more than 108 times greater than the therapeutic dose rate. It is difficult to predict the nature of processes in tissues and its cells at such radiation intensities. To determine the effect of extreme dose rate on the radiosensitivity of tissues at the Angara-5-1 facility, experiments were conducted to determine the lethal dose (LD50/30) for laboratory mice. Our result on the study of the LD50/30 dose (~100 MGy/s) allows us to make a conclusion about a possible higher lethal dose than the power range of the doses used for medical purposes.

Авторлар туралы

V. Smirnov

Joint Institute for High Temperatures, Russian Academy of Sciences

Email: oleinik@triniti.ru
Ресей, Moscow, 125412

V. Bozhenko

Russian Scientific Center of Roentgenoradiology

Email: oleinik@triniti.ru
Ресей, Moscow, 117997

T. Gimadova

State Research Center Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

Email: oleinik@triniti.ru
Ресей, Moscow, 123098

E. Grabovski

Troitsk Institute for Innovation and Fusion Research

Email: oleinik@triniti.ru
Ресей, Moscow, 142190

A. Gritsuk

Troitsk Institute for Innovation and Fusion Research

Email: oleinik@triniti.ru
Ресей, Moscow, 142190

A. Ivanov

Russian Scientific Center of Roentgenoradiology

Email: oleinik@triniti.ru
Ресей, Moscow, 117997

G. Oleinik

Troitsk Institute for Innovation and Fusion Research

Хат алмасуға жауапты Автор.
Email: oleinik@triniti.ru
Ресей, Moscow, 142190

E. Khmelevskii

Hertsen Moscow Oncology Research Center, Branch of FSBI NMRRC of the Ministry of Health of Russia

Email: oleinik@triniti.ru
Ресей, Moscow, 125284

A. Tsov’yanov

State Research Center Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

Email: oleinik@triniti.ru
Ресей, Moscow, 123098

A. Shishkin

Russian Scientific Center of Roentgenoradiology

Email: oleinik@triniti.ru
Ресей, Moscow, 117997

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML

© Pleiades Publishing, Ltd., 2018